Changing TACTICS in intermediate HCC: TACE plus sorafenib.

Radu, Pompilia; Dufour, Jean-François (2020). Changing TACTICS in intermediate HCC: TACE plus sorafenib. Gut, 69(8), pp. 1374-1376. BMJ Publishing Group 10.1136/gutjnl-2020-320692

[img]
Preview
Text
1374.full.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (217kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

UniBE Contributor:

Radu, Iuliana-Pompilia and Dufour, Jean-François

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0017-5749

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Thi Thao Anh Pham

Date Deposited:

11 Sep 2020 15:08

Last Modified:

13 Mar 2021 11:39

Publisher DOI:

10.1136/gutjnl-2020-320692

PubMed ID:

32169908

Uncontrolled Keywords:

cancer liver

BORIS DOI:

10.7892/boris.146471

URI:

https://boris.unibe.ch/id/eprint/146471

Actions (login required)

Edit item Edit item
Provide Feedback